Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001062993-25-014700

Chief Executive Officer gave up 4,305 shares (to pay taxes)

  • Chief Executive Officer acquired 8,543 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Chief Executive Officer 2025-08-15 Option exercise +8,543 55,273 D
Kelderman Kim Chief Executive Officer 2025-08-15 Shares withheld for taxes −4,305 $53.60 $230,748 50,968 D
Derivatives
Kelderman Kim Chief Executive Officer 2025-08-15 Option exercise · Restricted Stock Units −8,543 17,087 D
Kelderman Kim Chief Executive Officer 2025-08-15 Grant or award · Performance Restricted Stock Units +70,708 70,708 D
Kelderman Kim Chief Executive Officer 2025-08-15 Grant or award · Restricted Stock Units +35,354 35,354 D
Kelderman Kim Chief Executive Officer 2025-08-15 Grant or award · Stock Options (Right to Buy) +90,441 90,441 D
Loading xslF345X05/form4.xml…